Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Telemedycyna PolskaWAR:TMP +1.56%28 5-Year Yield-on-Cost % is 0.00 as of Aug. 02, 2026. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Telemedycyna Polska ranks worse than 363636% on this metric.
Telemedycyna Polska's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Telemedycyna Polska's 5-Year Yield-on-Cost % or its related term are showing as below:
WAR:TMP's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.99 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Telemedycyna Polska (WAR:TMP) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Telemedycyna Polska 5-Year Yield-on-Cost % Related Terms
WAR:TMP vs VEEV, BTSG, HQY: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, Telemedycyna Polska's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telemedycyna Polska 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Telemedycyna Polska's 5-Year Yield-on-Cost % falls into.
Telemedycyna Polska 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Telemedycyna Polska (WAR:TMP) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Telemedycyna Polska and its competitors. According to the industry distribution chart, Telemedycyna Polska ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Telemedycyna Polska's 5-Year Yield-on-Cost % too high?
Telemedycyna Polska's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Telemedycyna Polska ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #999999 out of 275 companies for 5-Year Yield-on-Cost %. This places Telemedycyna Polska in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.99, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Telemedycyna Polska and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telemedycyna Polska's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?
Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued.
The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82.
GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.
Key valuation signals for WAR:TMP:
5-Year Yield-on-Cost %: 0.00
GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score
Get the complete analysis for WAR:TMP
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:TMP has been successfully added to your 
